David Lebovitz
Stock Analyst at Citigroup
(1.92)
# 1059
Out of 5,329 analysts
126
Total ratings
73.68%
Success rate
7.23%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceutic... | Maintains: Strong Buy | 338 351 | 255.12 | 37.58% | 31 | Mar 21, 2025 | |
MDGL Madrigal Pharmaceuti... | Maintains: Strong Buy | 378 469 | 326.72 | 43.55% | 4 | Feb 27, 2025 | |
BMRN Biomarin Pharmaceuti... | Maintains: Neutral | 81 82 | 62.7 | 30.78% | 3 | Feb 20, 2025 | |
CRNX Crinetics Pharmaceut... | Maintains: Strong Buy | 70 74 | 33.6 | 120.24% | 2 | Nov 14, 2024 | |
MIRM Mirum Pharmaceutical... | Maintains: Strong Buy | 37 38 | 43.47 | -12.58% | 1 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 29 17 | 49.5 | -65.66% | 5 | Oct 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 111 92 | 99.27 | -7.32% | 6 | Feb 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 57 54 | 63.8 | -15.36% | 5 | Aug 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 408 372 | n/a | n/a | 5 | May 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 10 | n/a | n/a | 5 | May 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 38 35 | 31.79 | 10.1% | 6 | May 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 16 17 | 1.7 | 900% | 11 | Apr 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 11 | 0.93 | 1082.8% | 7 | Feb 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 193 220 | n/a | n/a | 5 | Feb 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 50 500 | n/a | n/a | 2 | Dec 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 45 44 | n/a | n/a | 10 | Nov 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 194 199 | 166.64 | 19.42% | 11 | Nov 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 510 480 | 6.78 | 6979.65% | 2 | Nov 3, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 27 26 | n/a | n/a | 2 | Aug 13, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 119 129 | n/a | n/a | 3 | Mar 6, 2018 |